Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
Sundquist E, Kauppila JH, Veijola J, Mroueh R, Lehenkari P, Laitinen S, Risteli J, Soini Y, Kosma VM, Sawazaki-Calone I, Macedo CC, Bloigu R, Coletta RD, Salo T.
Sundquist E, et al. Among authors: veijola j.
Br J Cancer. 2017 Feb 28;116(5):640-648. doi: 10.1038/bjc.2016.455. Epub 2017 Jan 17.
Br J Cancer. 2017.
PMID: 28095396
Free PMC article.